Eli Lilly’s Obesity Drug Helped People Lose 25% of Their Weight in Latest Trial

New research suggests that Eli Lilly’s tirzepatide can boost existing efforts to lose weight. The company’s latest clinical trial found that people who dropped at least 5% of their weight before taking the drug went on to lose substantially more weight than those who took a placebo. Those in the treatment group…

Read more…